Mesuol, a natural occurring 4-phenylcoumarin, inhibits HTV-1 replication by targeting the NF-κB pathway

被引:56
作者
Márquez, N
Sancho, R
Bedoya, LM
Alcamí, J
López-Pérez, JL
San Feliciano, A
Fiebich, BL
Muñoz, E
机构
[1] Univ Cordoba, Fac Med, Dept Biol Celular Fisiol & Immunol, Cordoba 14004, Spain
[2] Inst Salud Carlos III, Ctr Biol Fundamental, Crt Majadahonda Pozuelo, Madrid 28220, Spain
[3] Univ Salamanca, Fac Farm, Dept Quim Farmaceut, E-37007 Salamanca, Spain
[4] Univ Freiburg, Sch Med, Dept Psychiat & Psychotherapy, D-79104 Freiburg, Germany
关键词
4-phenyl-coumarins; mesuol; HIV-1; LTR; NF-kappa B;
D O I
10.1016/j.antiviral.2005.02.006
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Coumarins and structurally related compounds have been recently shown to inhibit replication of human immunodeficiency virus (HIV) and thus, exhibit a therapeutic potential. In this study we report that mesuol and isomesuol, two 4-phenyl coumarins. isolated from the tree Marila pluricostata, suppress HIV-1 replication in Jurkat T cells. These coumarins do not affect the reverse transcription and intregration steps of the viral cycle and their antiviral effect is additive with that of azidothymidine (AZT). In addition, mesuol inhibits TNF alpha-induced HIV-1-LTR transcriptional activity by targeting the nuclear factor-kappa B (NF-kappa B) pathway. While mesuol does not prevent either the binding of NF-kappa B to DNA or the phosphorylation and degradation of NF-kappa B inhibitory protein, I kappa B alpha, it inhibits the phosphorylation and the transcriptional activity of the NF-kappa B p65 Subunit in TNF alpha-stimulated cells. These results highlight the potential of the NF-kappa B transcription factor as a target for anti-HIV-1 compounds Such as 4-phenyl coumarins, which could serve as lead compounds for the development of additional therapeutic approaches against AIDS. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:137 / 145
页数:9
相关论文
共 44 条
[1]
ABSOLUTE DEPENDENCE ON KAPPA-B RESPONSIVE ELEMENTS FOR INITIATION AND TAT-MEDIATED AMPLIFICATION OF HIV TRANSCRIPTION IN BLOOD CD4 T-LYMPHOCYTES [J].
ALCAMI, J ;
DELERA, TL ;
FOLGUEIRA, L ;
PEDRAZA, MA ;
JACQUE, JM ;
BACHELERIE, F ;
NORIEGA, AR ;
HAY, RT ;
HARRICH, D ;
GAYNOR, RB ;
VIRELIZIER, JL ;
ARENZANASEISDEDOS, F .
EMBO JOURNAL, 1995, 14 (07) :1552-1560
[2]
Activation of integrated provirus requires histone acetyltransferase - p300 AND P/CAF are coactivators for HIV-1 Tat [J].
Benkirane, M ;
Chun, RF ;
Xiao, H ;
Ogryzko, VV ;
Howard, BH ;
Nakatani, Y ;
Jeang, KT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (38) :24898-24905
[3]
FUNCTIONAL ROLES FOR THE TATA PROMOTER AND ENHANCERS IN BASAL AND TAT-INDUCED EXPRESSION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 LONG TERMINAL REPEAT [J].
BERKHOUT, B ;
JEANG, KT .
JOURNAL OF VIROLOGY, 1992, 66 (01) :139-149
[4]
The two NF-κB activation pathways and their role in innate and adaptive immunity [J].
Bonizzi, G ;
Karin, M .
TRENDS IN IMMUNOLOGY, 2004, 25 (06) :280-288
[5]
Highly productive infection with pseudotyped human immunodeficiency virus type 1 (HIV-1) indicates no intracellular restrictions to HIV-1 replication in primary human astrocytes [J].
Canki, M ;
Thai, JNF ;
Chao, W ;
Ghorpade, A ;
Potash, MJ ;
Volsky, DJ .
JOURNAL OF VIROLOGY, 2001, 75 (17) :7925-7933
[6]
CHAKRABORTY D. P., 1966, TETRAHEDRON LETT, V46, P5727
[7]
Requirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human retroviruses human T-cell lymphotropic virus I and HIV-1 [J].
Chun, RF ;
Jeang, KT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (44) :27888-27894
[8]
VPR IS REQUIRED FOR EFFICIENT REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN MONONUCLEAR PHAGOCYTES [J].
CONNOR, RI ;
CHEN, BK ;
CHOE, S ;
LANDAU, NR .
VIROLOGY, 1995, 206 (02) :935-944
[9]
Plant substances as anti-HIV agents selected according to their putative mechanism of action [J].
Cos, P ;
Maes, L ;
Vanden Berghe, D ;
Hermans, N ;
Pieters, L ;
Vlietinck, A .
JOURNAL OF NATURAL PRODUCTS, 2004, 67 (02) :284-293
[10]
DARCY WG, 1980, ANN MO BOT GARD, V67, P969